Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heyan Kuntai capsule for diminished ovarian function
ChiCTR-IPR-16009199Phase 4Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Oct 2016
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Kuntai in primary ovarian insufficiency (POI) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoints: Antral follicle count and Anti-mullerian hormone. Planned start Oct 2016; status: not yet recruiting.
02
Drugs
Kuntai
03
Conditions
primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on ChiCTR-IPR-16009199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009199.